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Abstract
Background: DNA polymerase δ is essential for eukaryotic DNA replication and also plays a role
in DNA repair. The processivity of this polymerase complex is dependent upon its interaction with
the sliding clamp PCNA and the polymerase-PCNA interaction is largely mediated through the p66
polymerase subunit. We have analysed the interactions of the human p66 DNA polymerase δ
subunit with PCNA and with components of the DNA polymerase δ complex in vivo.
Results: Using the two-hybrid system, we have mapped the interaction domains for binding to the
p50 polymerase δ subunit and with PCNA to the N-terminus and the C-terminus of p66,
respectively. Co-immunoprecipitation experiments confirm that these interaction domains are
functional in vivo. Expression of EGFP-p66 shows that it is a nuclear protein which co-localises with
PCNA throughout the cell cycle. p66 is localised to sites of DNA replication during S phase and to
repair foci following DNA damage. We have identified a functional nuclear localisation sequence
and shown that localisation to replication foci is not dependent upon active nuclear import. Sub-
domains of p66 act as dominant negative suppressors of colony formation, suggesting that p66
forms an essential structural link between the p50 subunit and PCNA. Analysis of the C-terminal
PCNA binding motif shows that deletion of the QVSITGFF core motif results in a reduced affinity
for PCNA, while deletion of a further 20 amino acids completely abolishes the interaction. A
reduced affinity for PCNA correlates with reduced targeting to replication foci. We have confirmed
the p66-PCNA interaction in vivo using fluorescence resonance energy transfer (FRET) techniques.
Conclusion: We have defined the regions of p66 required for its interaction with PCNA and the
p50 polymerase subunit. We demonstrate a functional link between PCNA interaction and
localisation to replication foci and show that there is a direct interaction between p66 and PCNA
in living cells during DNA replication. The dominant negative effect upon growth resulting from
expression of p66 sub-domains confirms that the p66-PCNA interaction is essential in vivo.
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Background
The polymerisation of deoxyribonucleotides into DNA is
one of the most fundamental processes of life and is car-
ried out by DNA polymerases. A wide variety of these
enzymes exist, including the accurate polymerases α, β, δ,
ε and γ and also the more recently discovered translesion
polymerases, which can show a more flexible substrate
specificity [1]. The replicative polymerases all exist as
multi-protein assemblies which show complex patterns of
interaction, not only between individual subunits, but
also with other components of the repair and replication
machinery [1]. Many of the components of the DNA rep-
lication apparatus also show interactions with elements of
the networks which regulate cell cycle progression and
checkpoint control.
Chromosomal replication in eukaryotic cells requires
three distinct DNA polymerases: α, δ and ε. The pol α-
associated primase subunits synthesise oligonucleotides
which are elongated for a short length (approximately 35
nucleotides) by the large catalytic subunit of DNA
polymerase α. These short RNA-DNA segments are then
elongated by pol δ or ε through a series of reactions in
which the pol α-primase complex is displaced by Replica-
tion Factor C (RFC)-PCNA. The precise roles played by pol
δ and pol ε are still not completely clear. Studies using
purified protein preparations in SV40 DNA replication in
vitro show that pol α and pol δ are sufficient for the com-
pletion of DNA replication, suggesting that pol δ acts as
the major DNA replicative polymerase [2]. However, we
also know that pol ε is located at or near the replication
fork and evidence for a direct role for pol ε in replication
has emerged from Xenopus cell free systems [3,4]. Pol δ
plays an essential role in both DNA replication and repair:
biochemical and genetic studies have implicated pol δ in
mismatch repair [5], nucleotide excision repair [6], base
excision repair [7,8] and double strand break repair
[9,10]. The action of pol δ as a processive enzyme requires
its interaction with proliferating cell nuclear antigen
(PCNA) which functions as a molecular sliding clamp and
which is loaded onto DNA by the action of the RFC com-
plex [2,11,12].
Recent studies in fission yeast (S. pombe) and mammalian
cells have shown that the native form of DNA polymerase
δ consists of four subunits acting as a heterotetramer [13-
15]. The large catalytic subunit, p125, forms a tightly asso-
ciated heterodimer with the p50 subunit and this dimeric
form of the enzyme has been extensively studied. The
function of the smallest subunit (p12) is still poorly
understood. In S. pombe, deletion of the p12 homologue,
Cdm1, does not affect cell proliferation or cause sensitiv-
ity to DNA damaging agents [16]. In vitro reconstitution
experiments using purified human proteins have shown
that p12 is not essential for PCNA-dependent DNA repli-
cation, but that it is required to give a polymerase activity
comparable to that of the native pol δ complex isolated
from cell extracts [17-19]. In S. pombe, over-expression of
Cdm1 can rescue temperature sensitive alleles in each of
the genes encoding the other DNA polymerase δ subunits
[16]. This is consistent with a model in which this subunit
stabilises the pol δ complex.
Studies in S. pombe identified Cdc27 as a subunit of DNA
polymerase  δ. The catalytic subunit, Pol3, interacts
directly with the S. pombe homologue of the p50 subunit,
Cdc1 [20]. Cdc1 in turn interacts with Cdc27, which is the
homologue of p66 [21]. Cdc27 interacts directly with
PCNA and this interaction is mediated by a conserved
PCNA binding motif [21,22]. Reconstitution of the subu-
nits of DNA pol δ from S. pombe has shown that although
the three-subunit polymerase complex shows low basal
processivity, this is markedly increased by the addition of
Cdc27 in PCNA-dependent in vitro assays. Both the three-
subunit complex and four subunit complex containing
Cdc27 in which the PCNA-binding motif has been deleted
both required PCNA for processive polymerisation, sug-
gesting a second site within the complex for PCNA inter-
action, possibly within the large catalytic subunit Pol3
[23]. Genetic experiments in S. pombe have shown that the
ability of Cdc27 to bind simultaneously to Cdc1 (the p50
homologue) and to PCNA is essential for its biological
function [21]. The p66 subunit and its homologues all
contain a consensus PCNA-binding domain at the C-ter-
minus which is homologous to that found in p21(WAF1/
Cip1), Fen1, DNA ligase I, the large subunit of RFC and
many other proteins involved in DNA replication, repair
and modification [22]. Based on gel filtration experi-
ments, the S. pombe polymerase δ complex was previously
thought to exist as a dimer with Cdc27 mediating the
dimer interface [15]. It is now known that these results
were due to the highly asymmetrical shape of Cdc27 and
that pol δ exists as a monomer [23]. Similar results have
been found in S. cerevisiae [24].
The homologue of Cdc27 in S. cerevisiae is Pol32,
although a homologue of Cdm1/p12 has not been found.
In vitro experiments show that the addition of Pol32 to the
purified dimeric form of the polymerase results in an
increased processivity rate and Pol32 interacts with PCNA
[25]. Surprisingly, Pol32 is not essential; deletion of the
POL32 gene results in a temperature sensitive phenotype
and sensitivity to DNA damage [26]. POL32 deletion is
lethal when combined with a temperature sensitive muta-
tion in POL3 which encodes the pol δ catalytic subunit.
This suggests that, in contrast to S. pombe, the interaction
between pol δ and PCNA can be mediated by some other
mechanism in S. cerevisiae. In native gel analysis using
purified proteins, a well-defined complex between
polymerase δ and PCNA was only observed when Pol32BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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was present containing an intact PCNA-binding domain.
However, in in vitro DNA replication assays, loss of the
p50-binding domain had a far stronger effect than loss of
the PCNA-binding domain on PCNA-dependent
polymerase processivity. This suggests that a region in
addition to the PCNA-binding consensus in Pol32 con-
tributes to the interaction of PCNA with the polymerase
complex [27].
A direct interaction between PCNA and the p125 subunit
has been demonstrated in mammalian cells [17,28,29],
although this interaction does not seem to exist in either
S. pombe or S. cerevisiae and some studies have failed to
find it in human cells [26,30-32].
In mammalian cells, the Cdc27 homologue (p66) was
identified as a polymerase δ subunit by affinity chroma-
tography using either PCNA or anti-p125 antibodies to
isolate the polymerase complex [17,33,34]. Interaction
studies using purified proteins have shown that p66 binds
directly to PCNA and p50. p66 also stabilises the associa-
tion between p125 and p50 and increases the overall
affinity of the polymerase δ complex for PCNA [17,35].
p66 was found to stimulate DNA synthesis by three- to
four-fold in the presence, but not in the absence of PCNA.
In contrast, basal DNA synthesis by the p125-p50 dimeric
complex is not stimulated by PCNA [32,35,36]. However,
these results are at variance with results showing that the
processivity of the dimeric p125-p50 form of the polymer-
ase could be stimulated by PCNA [37]. Using purified pro-
teins from S. cerevisiae, DNA replication by a dimeric
complex of Pol3-Pol31, which is equivalent to p125-p50
in human cells, was PCNA-dependent, though proceeded
inefficiently and was characterised by frequent pausing.
Addition of Pol32, which is equivalent to p66, resulted in
significantly increased PCNA-dependent processivity
[25].
Here we describe results from our examination of the
interactions of human p66 pol δ subunit with PCNA and
with components of the DNA polymerase δ complex in
vivo. We have mapped interaction domains by expressing
various regions of the protein and also analysed their sub-
cellular localisation. We have measured fluorescence reso-
nance energy transfer (FRET) to determine if p66 forms
direct, rather than complex-mediated, interactions in vivo.
Results
Two-hybrid analysis of p66-protein interactions
Two-hybrid analysis was used to investigate the potential
interactions of p66 with the p50 subunit and with PCNA.
Constructs were made expressing full-length p66 as
fusions either with the transcriptional activation domain
of GAL4 (pACT-p66) or the DNA binding domain (pAS-
p66). As shown in Figure 1, the fusion protein expressed
from pAS-p66 showed a highly specific interaction with S.
pombe PCNA. Human PCNA could not be used as a pACT
fusion as this construct shows strong self-activation. There
was no detectable p66-p66 interaction suggesting that the
protein does not dimerise. This correlates with observa-
tions seen with S. cerevisiae: although the p66 homologue
Pol32 was initially thought to dimerise in the two hybrid
system it was later found that this was due to the bridging
activity of the endogenous S. cerevisiae PCNA [24]. S.
pombe Cdc27 cannot be analysed in this way as it results
in reporter activation when expressed as a fusion with the
GAL4 DNA binding domain (data not shown). No inter-
action was seen between p66 and Cdc27, or between p66
and any other proteins tested, including those known to
interact with PCNA in the replication complex such as
Fen1 or uracil DNA glycosylase (UNG2). Although expres-
sion of pAS-p50 results in some background reporter acti-
vation, it is clear that there is a significant interaction
between the p50 and p66 subunits (Fig. 1, lower panel).
This is also seen using pAS-p66 and pACT-p50 constructs
(data not shown). No significant levels of interaction was
seen between the S. pombe homologue of p66, Cdc27, and
human p50. It seems likely that this reflects the low levels
of homology between p66 and Cdc27, which is less than
24% overall [33].
To identify other proteins which interact with p66, a two-
hybrid screen was undertaken with the full-length protein
fused to the GAL4 DNA binding domain. 1.4 × 106 clones
were screened in two separate experiments and two inde-
pendent positive clones identified with strong activation
of the reporters His3 and β-galactosidase. These clones
showed a very specific interaction with p66 when com-
pared with a range of pACT constructs and were both
found to encoded full-length clones of p50. To map the
domain of p66 responsible for the interaction with p50,
various regions of p66 were tested in the two-hybrid sys-
tem. The smallest clone which showed an interaction was
that encoding amino acids 1 – 144 (pACT-p66S2) which
is a region similar to, though slightly smaller than, the
Cdc1-interacting region in Cdc27 in S. pombe [21].
Interactions in human cells
To study the interaction of p66 with PCNA further we
used various constructs expressing p66 in human U2OS
osteosarcoma cells as fusions with Enhanced Green Fluo-
rescent Protein (EGFP). A conserved PCNA-binding
domain is localised at the C-terminus of p66 and this is
conserved between other p66 homologues [21,33-35].
Various C-terminal deletions of p66 were expressed as
EGFP-fusion proteins (see Figure 2 for details of con-
structs) and a construct expressing a full length EGFP-p66
fusion protein mutated in a predicted nuclear localisation
sequence also tested (p66NLS; see below for details).
Immunoprecipitation was carried out from soluble cellBMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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extracts using an anti-EGFP antibody. Interaction with
endogenous PCNA was analysed by Western blotting with
an anti-PCNA antibody (Figure 3a). These results show
that PCNA co-immunoprecipitates with full length p66
when fused to EGFP. We used both transiently transfected
EGFP-p66 and a stable cell line expressing this construct.
The slightly higher level of PCNA seen with the transiently
transfected cells reflects the higher levels of EGFP-p66
expressed (data not shown). We were also able to show
co-immunoprecipitation of myc-tagged p66 with PCNA
using the polyclonal rabbit anti-PCNA polyclonal anti-
body 3009 (data not shown). Compared to transient
transfection of the full-length construct, deletion of the C-
terminal 11 amino acids which contains the conserved
PCNA-binding domain QVISITGFF reduced, though did
not completely abolish the interaction of the EGFP-tagged
p66 with PCNA. However, deletion of the C-terminal 31
amino acids abolishes the interaction completely. The lev-
els of expression of the full-length p66, ∆31 and ∆11 EGFP
fusion constructs were indistinguishable in these experi-
ments (data not shown). The N-terminal 144 amino acids
which interacted with p50 in the two-hybrid system show
no detectable interaction with PCNA (data not shown).
Immunoprecipitation of p50 from these extracts followed
by detection of EGFP by Western blot confirms the two
hybrid data that the region composed of amino acids 1–
144 expressed by pEGFP-p66S2 is sufficient for the inter-
action with p50 (Figure 3b). These results confirm that the
N-terminal 144 amino acids of p66 is sufficient for the
interaction with p50 and show that the interaction of p66
with PCNA is mediated in vivo by the conserved PCNA-
binding motif, though N-terminal flanking sequences are
also important. They show that p66 can interact with p50
independently of its interaction with PCNA. We also show
that p66 mutated in a putative nuclear localisation
sequence is capable of binding to both p50 and PCNA
(see below).
Two-hybrid analysis of p66 and p50 interactions Figure 1
Two-hybrid analysis of p66 and p50 interactions. β-
galactosidase assays were carried out as described in the 
Methods section using strain Y190 co-transformed with plas-
mids as indicated. Top panel: various proteins expressed as 
fusions with the transcription activation domain of GAL4 
(pACT) were co-expressed with human p66 expressed as a 
fusion with the sequence specific DNA-binding domain of 
GAL4 (pAS). Lower panel: activation domain fusions were 
co-expressed with human p50 fused with the sequence spe-
cific DNA-binding domain of GAL4. pACT constructs are as 
described: p66 (Methods section); Pcn1 (S. pombe PCNA) 
[43]; Cdc27 (S. pombe p66 homologue) [21]; Fen1 (human 
repair and replication endonuclease) [45]; UNG2 (human 
uracil DNA glycosylase) [44] and S. cerevisiae Snf1 as a nega-
tive control.
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Subclones of p66 expressed as Gal4 and EGFP fusions used  for interaction analysis Figure 2
Subclones of p66 expressed as Gal4 and EGFP fusions 
used for interaction analysis. The regions of p66 shown 
were expressed in mammalian and two hybrid vectors and 
were made as described in the Methods section. The con-
structs p66∆11, p66∆21 and p66∆31 have the C-terminal 11, 
21 and 31 amino acids deleted, respectively. p66S2 expresses 
amino acids 1–144; p66S1 expresses amino acids 1–375.
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Further evidence to support the role of p66 of mediating
the p50-PCNA interaction is shown in Figure 3c. Anti-p50
antibodies were used for immunoprecipitation from
either untransfected cells or those stably expressing EGFP-
p66. It can be see that the amount of PCNA co-immuno-
precipitated is significantly increased in the cell expressing
the increased levels of p66. This suggests that p66 acts to
mediate or otherwise stabilise the interaction between
p50 and PCNA, and that the level of p66 in the cell is lim-
iting for this process.
We have shown that the p66 protein interacts with p50
and PCNA and mapped the regions involved in these
interactions. We predicted that high-level expression of
regions of p66 which interact with only one of p50 or
PCNA would be deleterious to the cell by acting as a dom-
inant negative. To investigate this phenomenon we under-
took clonogenic assays to determine if expression of
various domains was deleterious to the cell over a period
of time. Our results show that while expression of EGFP-
p66 was indistinguishable from the EGFP control, expres-
sion of either EGFP-p66∆11 or EGFP-p66S2 which do not
interact with PCNA, results in reduced cell proliferation
following selection for plasmid maintenance (Figure 4).
Subcellular localisation of p66
During S phase, p66 localised to distinct nuclear spots
which are typical of replication foci (see below; Figure 6).
These foci or factories represent a conglomeration of pro-
teins involved in DNA replication and post-replicative
processing which are brought together at sites of DNA rep-
lication [38,39]. We also found that, following DNA dam-
age outside S-phase, p66 was localised to large foci within
the nucleus which are typical of sites of DNA repair. This
is confirmed by the co-localisation of PCNA to these foci.
Figure 5 (panels A and B) show cells fixed 30 minutes after
a UV dose of 40 Jm-2. The upper cell shows a pattern of
p66 and PCNA localisation which is typical of S phase,
while the lower cell shows a pattern typical of DNA repair.
This pattern of localisation is consistent with the role of
DNA polymerase δ in repair, especially nucleotide exci-
sion repair, and confirms that the p66 subunit is specifi-
cally involved.
Analysis of the p66 protein sequence with the PredictNLS
program lead to the identification of a single nuclear
localisation sequence consisting of amino acids 319 – 326
(KKRRRIKL) [40]. Using site-directed mutagenesis, we
created the plasmid pEGFP-p66NLS which expresses
EGFP-p66 with the residues 320–322 (KRR) are mutated
to NGG. This EGFP-p66NLS fusion protein was no longer
exclusively localised to the nucleus, but was distributed
throughout the nucleus and cytoplasm, indicating that
this sequence represents a functional nuclear localisation
sequence (Figure 5, panels C and D). Interestingly, this
protein is still capable of localising to replication foci dur-
ing S phase and could still interact with both PCNA and
Western blot analysis of co-immunoprecipitation  experiments Figure 3
Western blot analysis of co-immunoprecipitation 
experiments. Extracts were prepared from cells expressing 
various EGFP-p66 fusion proteins as described in the Meth-
ods section and immunoprecipitation carried out as 
described. Cells were transfected with constructs expressing 
EGFP or EGFP fusions as indicated. "control" indicates non-
transfected cells. Panel A: immunoprecipitation was carried 
with a rabbit polyclonal anti-EGFP antibody (Ab290, Abcam). 
Bound proteins were separated by SDS-PAGE and Western 
blot analysis carried out with a mouse anti-PCNA antibody 
(PC10). Panel B: immunoprecipitation was carried out with a 
rat anti-p50 antibody and the blot probed with a mouse anti-
GFP antibody (Roche). Panel C: immunoprecipitation was 
carried out with a rat anti-p50 antibody and the blot probed 
with a mouse anti-PCNA antibody (PC10).BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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p50 (Figure 3), indicating that specific nuclear targeting is
not a prerequisite for these processes. High levels of
expression of this protein were not significantly deleteri-
ous to cell growth in colony assay experiments, suggesting
that this NLS mutant was still fully functional and did not
act as a dominant negative (Figure 4).
Many proteins have been identified which interact with
PCNA through the small conserved PCNA-binding motif
[22]. In some cases, this motif has been identified quite
independently as a targeting sequence for localisation to
replication foci [41] and a model has been proposed in
which PCNA acts as an assembly platform for the replica-
tion machinery [39]. The conserved PCNA-binding motif
in p66 is located at the extreme C-terminus, and we have
already shown that this sequence is involved in the inter-
action of p66 with PCNA. To investigate the role of this
domain in p66 sub-nuclear localisation, cells were trans-
formed with the pEGFP-p66∆11 and pEGFP-p66∆31 con-
structs. These proteins were localised to the nucleus, but
did not show a punctate pattern of localisation (data not
shown), suggesting that they were not exclusively local-
ised to replication foci. We have already shown that dele-
tion of the last 10 amino acids significantly, though not
completely, abolishes the interaction with PCNA while
deletion of the last 30 amino acids completely abolishes
this interaction. Our results indicate that complete abro-
gation of the p66-PCNA interaction is not required to
abolish replication foci targeting. It also demonstrates
that the interaction of p66 with PCNA is not required for
nuclear localisation.
Since proteins that co-localise do not necessarily interact
directly, we explored whether EYFP-p66 and ECFP-PCNA
directly interact in vivo. To do this we used fluorescence
resonance energy transfer (FRET) technology to determine
whether the fluorescent tags (ECFP and EYFP) are closer
than 100 Å/10 nm [42]. FRET occurs only when the inten-
sity of emitted light measured in the presence of two fluo-
rescently tagged proteins are greater than emitted light
from cells transfected with ECFP- or EYFP-tagged proteins
alone (i.e. background levels). The details of the calcula-
tions used to analyse the FRET signal are described in the
Methods section. It is expected that, in at least some repli-
cation forks within a replication focus, ECFP and EYFP
tagged PCNA will bind adjacently in the trimeric PCNA
clamp, thus tagged PCNA were used as positive control.
Furthermore, since no interaction between UNG2 and
p66 could be detected in the yeast two-hybrid assay and
there has been no report of an interaction between UNG2
and p66, we used ECFP-UNG2 and EYFP-p66 as a nega-
tive control for the analysis of these in vivo interactions in
human cells. We calculated FRET from the mean intensi-
ties within a replication focus (the region of interest, ROI)
and normalized these values against the different protein
Subdomains of p66 can act as dominant negative suppressors  of proliferation in clonogenic assays Figure 4
Subdomains of p66 can act as dominant negative sup-
pressors of proliferation in clonogenic assays. Clono-
genic assays were carried out to assess the effect of various 
p66 constructs on colony formation in U2OS cells; see the 
Methods section for details. Cells were plated at densities of 
5 × 104 (left hand side) and 2.5 × 104 per well (right hand 
side) prior to transfection with EGFP constructs and grown 
under selective conditions for 10 to 20 days before being 
fixed and stained with Giemsa. The figure shows a represent-
ative result. Panel A: pEGFP; panel B: pEGFP-p66; panel C: 
pEGFP-p66∆11; panel D: pEGFP-p66S2; panel E: pEGFP-
p66NLS.BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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p66 is directed to the nucleus by a single nuclear localisation sequence and is located to sites of DNA repair following UV  damage Figure 5
p66 is directed to the nucleus by a single nuclear localisation sequence and is located to sites of DNA repair fol-
lowing UV damage. U2OS cells were fixed and stained as described in Materials and Methods. Panels A and B: cells tran-
siently transfected with the pEGFP-p66 construct were treated with 40 Jm-2 UV at 254 nm and fixed 30 minutes post-
treatment. Panel A: EGFP-p66 detected by an anti-EGFP antibody (Roche) (green); panel B: PCNA detected by staining with 
the anti PCNA-antibody 3009 (red). Panels C and D: cells transiently transfected with the pEGFP-p66NLS construct. Panel C: 
EGFP-p66NLS detected with the anti-EGFP antibody (green); panel D: cells stained with the anti-PCNA antibody as described 
above.BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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FRET analysis of p66 and PCNA co-localisation Figure 6
FRET analysis of p66 and PCNA co-localisation FRET analysis was carried out as described in the Methods section. Cells 
were co-transfected with two constructs as shown. PCNA was tagged with both ECFP and EYFP shown in green and red, 
respectively. p66 and p66∆ N145 were tagged with EYFP (shown in red) and UNG2 with ECFP (shown in green). Five of the 
representative high FRET values found within the given levels of intensities (donor intensities (I1, ID1) between 85–190, and 
acceptor intensities (I3, IA3) between 70–190. NFRET represents FRET normalized against protein expression levels. FRET is cal-
culated from the mean of the intensities within one region of interest (ROI) containing more than 25 pixels (i.e., one replication 
focus). Within ROI, all individual pixels had intensities below 250. More than 90% of the UNG2-p66 co-localising foci did not 
FRET (FRET<0, see the Methods section).
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expression levels, NFRET, in cells co-transfected with ECFP-
PCNA and EYFP- p66, ECFP-PCNA and EYFP-PCNA (pos-
itive control) and ECFP-UNG2 and EYFP-p66 (negative
control) (Figure 6). The NFRET levels of five representative
replication foci in the higher range of FRET values are
given. Varying NFRET levels among different replication
foci are as expected found since replication foci are
dynamic structures and in addition endogenous proteins
will compete with the tagged proteins for interactions. We
find that the NFRET levels between PCNA and p66 are sim-
ilar to NFRET between PCNA-PCNA. p66, PCNA and UNG2
are all localised to replication foci. In contrast, the NFRET
levels observed between PCNA and p66 are four to five
fold higher than between UNG2 and p66, indicating that
PCNA and p66 are not merely co-localised to the same
complex, but show a direct physical interaction in living
cells. To confirm that this interaction is not merely due to
the presence of both p66 and PCNA at the replication
fork, we show that there is still a positive FRET interaction
between PCNA and a p66 mutant which lacks the p50
interaction domain (p66DN145). By using FRET we can
clearly distinguish between co-localisation and
interaction.
Discussion
Several lines of conflicting evidence exist concerning the
mechanism of interaction of DNA polymerase δ with
PCNA. The catalytic subunit p125 shows low activity and
little response to PCNA stimulation when over-expressed
in insect cells. Although direct interaction between PCNA
and the p125 subunit appears to take place in mammalian
cells [17,28,29] this either does not occur or is extremely
weak in yeasts [26,31,32]. More recent work has shown
that the major interaction between PCNA and the DNA
polymerase complex is mediated by the third subunit,
which is p66, Cdc27 and Pol32 in mammalian cells, S.
pombe  and  S. cerevisiae, respectively. p66 homologues
have now been identified in a wide range of organisms,
but in general they have a very poor level of protein
sequence similarity with the exception of the conserved
PCNA-binding motif at the C-terminus.
Here we describe the analysis the protein interaction
domains of human p66 by expressing various tagged and
fusion proteins in cultured cells and we have correlated
their subcellular localisations with their interactions in
vivo. In our initial experiments using the two-hybrid sys-
tem we were able to show that p66 was able to interact
with both p50 and PCNA. This is similar to results seen in
the S. pombe and S. cerevisiae homologues of p66. We also
show that p66 does not dimerise in this system. In a two-
hybrid screen using p66 as bait, the only positive clones
identified were those expressing full-length p50. We did
not expect to identify human PCNA in this screen, as the
full-length protein when fused to the Gal4 activation
domain results in a construct that is self-activating and so
would be excluded as a false positive. The p50-interacting
domain was mapped to amino acids 1–144, which is sim-
ilar, though slightly smaller than the Cdc1 interaction
region in Cdc27.
Using various domains of p66 expressed as fusions with
EGFP in human cells, we were able to confirm that the
domain identified as interacting with p50 using the two-
hybrid system was also sufficient for the interaction in cell
extracts using co-immunoprecipitation experiments. This
domain showed no detectable interaction with PCNA. We
also found that high levels of expression of either the p50-
interacting or the PCNA-interacting domains are deleteri-
ous to cell proliferation over periods of growth selection
in colony assays. This indicates that these domains can act
as "dominant negatives" to compete for binding to the
endogenous p50 and PCNA.
Fine mapping of the PCNA-binding domain at the C-ter-
minus showed that the p66∆11 protein (which has the
minimal conserved PCNA-binding domain QVSITGFF
plus QRK deleted) significantly reduced, though did not
completely abolish binding to PCNA in co-immunopre-
cipitation assays. The deletion of an additional 20 amino
acids completely abolished the interaction, suggesting a
region N-terminal to the core-conserved domain makes a
significant contribution to the PCNA interaction. The
best-characterised incidence of a PCNA-interacting motif
is in the cell cycle regulatory protein p21WAF1. The crystal
structure of the PCNA-binding region from this protein
complexed with PCNA has been solved which shows that
the conserved motif makes a helical turn which has inter-
actions within a hydrophobic pocket on PCNA.
Sequences C-terminal to the motif make a β-sheet interac-
tion with the inter-domain linker region of PCNA. In pro-
teins such as DNA ligase I and the largest subunit of RFC
the conserved motif lies at the extreme N-terminus indi-
cating that N-terminal regions do not play a role in the
PCNA interaction. However, in p66 we see that sequences
lying up to 20 amino acids N-terminal to the conserved
motif clearly play a role in the interaction. The mecha-
nism by which this region interacts with PCNA awaits fur-
ther investigation. The conserved PCNA-binding motif
has been linked to replication foci targeting: in DNA ligase
I the N terminal 20 amino acids containing the PCNA-
binding motif are capable of directing localisation of het-
erologous proteins to replication foci [41]. However, we
show here that the p66-∆11 construct, which is still capa-
ble of binding to PCNA, does not appear to be targeted to
replication foci. This result is difficult to interpret, as it
may be that a small proportion of it, corresponding to the
smaller amount seen binding to PCNA, is present in
replication foci, but the amount is too low to be observed
microscopically. It is clear that we see a correlationBMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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between PCNA binding and localisation to replication
foci, with both these phenomena mediated by the
interaction of p66 with PCNA through the conserved
PCNA-binding motif.
These results correlate with those found for the p66
homologue, Cdc27, in S. pombe where binding to PCNA
and protein function in vivo could be correlated. Reynolds
et al. showed that the C-terminal 20 amino acids of Cdc27
were essential both for PCNA binding and protein func-
tion. However, high level expression of a construct lacking
the C-terminal 10 amino acids containing the core PCNA-
binding motif was still able to rescue growth of a cdc27∆
strain, though quite poorly. This suggests that regions of
Cdc27 N-terminal to the core PCNA binding domain may
also contribute to PCNA binding [21].
We have shown that p66 is a nuclear protein which is
excluded from the nucleolus and is localised to replica-
tion foci during S phase. This pattern of localisation is
shared with many proteins involved in DNA replication
such as PCNA, pol α, Fen1, DNA ligase I, RFC, RPA etc.
[38,39]. This pattern of co-localisation does not in itself
show that the proteins make a direct physical interaction.
To investigate this, we have used FRET analysis to substan-
tiate a direct interaction between p66 and PCNA in vivo.
We find that the NFRET between PCNA and p66 is similar
to the NFRET shown by the extremely stable PCNA-PCNA
interaction, (Figure 6) and are considerably higher than
between proteins that co-localise, but do not interact,
such as UNG2-p66. These results, together with the two
hybrid and co-immunoprecipitation data, strongly sup-
port a direct physical interaction between p66 and PCNA
in vivo.
In cell lines which stably express EGFP-p66 in addition to
endogenous p66 we see an increased amount of PCNA
associated with p50 compared to cells containing endog-
enous levels of p66. Since we already know that p66 can
interact with both p50 and PCNA, this is strongly sugges-
tive that the increased levels of p66 are stabilising the
interaction. This implies that p66 mediates this interac-
tion and that the level of p66 is a limiting factor for the
amount of the polymerase complex associated with
PCNA. This raises the interesting possibility that levels or
localisation of p66 may play a regulatory role in DNA
replication.
Conclusion
Previously published work on the human p66 DNA
polymerase δ subunit has shown that it forms part of the
polymerase complex and interacts with PCNA in cell
extracts [17,33,34]. p66 has been shown to bind p50 and
PCNA using purified proteins [17,35]. In this work, we
show that p66 interacts with p50 and PCNA using human
cell extracts, and have mapped the protein domains
involved in this interaction in vivo. The dominant negative
effect upon proliferation shown by p66 constructs which
cannot bind to PCNA suggests that the p66-PCNA interac-
tion is an essential one. We also show that p66 is located
to sites of DNA synthesis following DNA damage, which
demonstrates that this subunit is present in the form of
polymerase δ which is involved in DNA repair. We have
identified a nuclear localisation sequence and show that
p66 localisation to replication foci during S phase is not
dependent upon active nuclear import. Finally we show
that p66 is localised to replication foci in living cells using
FRET techniques and show that it interacts directly with
PCNA in these complexes.
Methods
Expression constructs
All DNA fragments made by PCR amplification were veri-
fied by DNA sequencing. The human p66 open reading
frame was cloned from the human cDNA clone HA2030
supplied as by Takahiro Nagase at the Kazusa DNA
Research Institute as a NcoI – BglII fragment to give the
plasmids pAS-p66 and pACT-p66. The pAS-p50 clone
(pGBT) was a kind gift from Dr. Stuart MacNeill,
University of Edinburgh. The pACT-p50 clone was identi-
fied by two-hybrid screening. pACT-p66S2 (which
expresses amino acids 1 – 144) was constructed by digest-
ing pACT-p66 with SacI and religating. pACT-p66S1
(which expresses amino acids 1 – 375) was constructed by
cloning the SacI fragment interior to the p66 open reading
frame into pACT-p66S2 to extend the open reading frame.
Clones of S. pombe PCNA in pAS and pACT are as previ-
ously [43]. Clones of UNG2 are as described [44]. Clones
of Fen1 are as described [45].
A NcoI – XhoI fragment was cloned from HA2030 into
pEG202 to give pEG-p66. A BamHI – XhoI fragment was
cloned from pEG-p66 into pEGFP-C3 (Clonetech)
digested with BglII – SalI to give pEGFP-p66 which
expressed full-length p66 fused to EGFP. Similarly, the
insert from pACT-p66S2 was cloned as an NcoI – XhoI
fragment into pEG202 to give pEG-KIA-S2 and the insert
from this plasmid cloned as an EcoRI – SalI fragment into
pEGFP-C3 to give pEGFP-p66S2. The deletion construct
pECFP-p66∆11 which does not express the C-terminal 11
amino acids of p66 was amplified by PCR as a BglII-Hin-
dIII fragment and cloned into pECFP-C1. Further C-termi-
nal truncations were generated from the original
construct, using the QuikChange site-directed mutagene-
sis method (Stratagene) to incorporate stop codons.
pEYFP-p66∆N145 contains a HindIII – BamHI fragment
created by PCR cloned into pEYFP-C1. The cloning of
ECFP-PCNA, EYFP-PCNA and UNG2ECFP constructs is as
previously described [46].BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
Page 11 of 13
(page number not for citation purposes)
Two hybrid screening
Two-hybrid analysis of proteins that interact with p66 was
carried out essentially as previously described using the S.
cerevisiae  strain Y190 which expresses LacZ and His3
reporter constructs under the control of the Gal1 pro-
moter [43]. For two-hybrid screening, Y190 cells contain-
ing pAS-p66 were further transformed with a human
cDNA library in pACT, which was a gift from Steve
Elledge. Putative interacting clones were identified by
their ability to grow on media containing 50 mM 3-ami-
notriazole (3-AT), and tested for expression of the LacZ
reporter by a filter lift assay for β-galactosidase activity. For
β-galactosidase assays, 5 ml of culture log phase culture
was washed once in water and the cell pellets permeab-
lised by repeated immersion in liquid nitrogen. At least 3
independent transformants were analysed in each case.
The pellets were resuspended in 1 ml of Z buffer contain-
ing 3% Brij 35 (Sigma) at 30°C and 0.2 ml of 4 mg/ml
ONPG in Z buffer added. The reaction was stopped by the
addition of 0.5 ml 1 M Na2CO3, cell debris was removed
by centrifugation, and the OD420  of the supernatant
measured. Units of β-galactosidase were calculated as:
Units = (1000 × OD420)/(t × v × OD600) where t = time of
reaction in minutes and v = volume of culture in ml.
Cell culture and transfection
Cells were grown at 37°C and 5% carbon dioxide, in a
humidified atmosphere. All cell types were grown in
DMEM (PAA Laboratories, GmbH), supplemented with
10% v/v Foetal Calf Serum (FCS), 100 units/ml penicillin
and 100 µg/ml streptomycin. Cells were transfected using
Lipofectamine 2000 (Invitrogen) or using a calcium phos-
phate technique (Profection, Promega), according to the
manufacturer's protocol, and harvested 24 hours post-
transfection.
Preparation of cell lysates and immunoprecipitation
Cells were transfected in 100 mm2 dishes, and harvested
by scraping into ice-cold PBS, followed by centrifugation
at 1500 rpm for 3 minutes. Cell pellets were lysed using
NP40 lysis buffer (50 mM TrisHCl (pH 8.0), 150 mM
NaCl, 1% (v/v) NP-40) containing Complete™ protease
inhibitors (Roche Biochemicals), and incubated at 4°C
for 30 minutes, followed by centrifugation at 14000 rpm
for 15 minutes. The resulting supernatants were decanted
into a fresh tube and stored at -20°C until used. Protein
concentrations were measured at 595 nm using the Bio-
Rad protein assay reagent (BioRad). The antibodies used
for immunoprecipitation were rabbit polyclonal anti-
PCNA (3009, Moravian Biotechnology Ltd.), rat mono-
clonal anti-p50 (7B4, kindly provided by Dr Heinz-Peter
Nasheuer) and rabbit polyclonal anti-GFP (Ab290,
Abcam). For each immunoprecipitation (IP), 1 µl of puri-
fied antibody, or 50 µl of tissue culture supernatant, was
added to 750 µg of soluble protein, previously pre-cleared
against protein G, and incubated overnight at 4°C with
gentle agitation. 20 µl of protein G slurry (50% (v/v) in
PBS) was added and incubated at 4°C for 1 hr with gentle
agitation. The beads were pelleted by centrifugation at
2000 rpm for 3 minutes, and subsequently washed exten-
sively with lysis buffer, prior to final resuspension with 20
µl of SDS loading buffer.
SDS-PAGE and western blotting
Electrophoresis was performed using the NuPage system
(Invitrogen). Either 10% or 4–12% Bis-Tris gradient gels
were used and run with MES buffer as supplied by the
manufacturer. Proteins were transferred to Immobilon-P
membranes (Millipore) using the conditions directed by
the manufacturer. Blots were blocked with 5% (w/v) milk
in PBS for 1 hour at room temperature and then rinsed
twice with PBS. Primary antibodies were diluted in 2%
milk in PBS and added to the blot at a concentration of 2
µg/ml of purified antibody or 1:1000 ascites/serum. This
was incubated for 1 hour at room temperature followed
by extensive washing with PBS 0.2% Tween-20. HRP-con-
jugated secondary antibodies were added, incubated and
washed as for primaries. Primary antibodies used were
mouse monoclonal anti-PCNA antibody (PC10) and
mouse monoclonal anti-EGFP antibody (Roche).
Peroxidase-coupled donkey anti-mouse IgG (Jackson
Immunoresearch) was used as secondary antibody.
Immunoblots were visualised by enhanced chemilumi-
nescence (ECL, Amersham Pharmacia), according to the
manufacturers instructions.
Immunofluorescence
Cells were grown and transfected in 2-well chamber slides
(Lab Tek). Cells were washed twice with ice-cold PBS, and
fixed with 4% (v/v) paraformaldehyde for 5 mins at room
temperature (RT), followed by another PBS wash. Cells
were subsequently permeabilised with 0.2% Triton X-100
in PBS for 10 minutes at RT. The primary antibodies used
were rabbit polyclonal anti-PCNA (3009, Moravian Bio-
technology Ltd.) diluted 1 in 5000, and mouse mono-
clonal anti-EGFP (Roche Biochemicals) diluted 1 in 500.
Secondary antibodies used were FITC-coupled donkey
anti-mouse, and Texas Red coupled donkey anti-rabbit
(both Jackson Immunoresearch), diluted as recom-
mended. All antibodies were diluted with 3% BSA in PBS.
Primary antibodies were added for 1 hour at 4°C. After
washing twice with 3% BSA in PBS, secondary antibodies
were added for 1 hour at 4°C, diluted as before. After
washing twice with PBS, nuclei were stained with DAPI
(Sigma) at a final concentration of 0.5 µg / ml in PBS.
Cells were washed again in PBS before mounting with one
drop of Hydromount (National Diagnostics) containing
2.5% (w/v) DABCO anti-fade (Sigma) and visualised on a
Zeiss MC100 fluorescence microscope.BMC Molecular Biology 2005, 6:17 http://www.biomedcentral.com/1471-2199/6/17
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Confocal microscopy and FRET measurements
A Zeiss LSM 510 Meta laser scanning microscope
equipped with a Plan-Apochromate 63x/1.4 oil immer-
sion objective was used to examine images of 1 µm thick
slices of live cycling HeLa cells grown in glass bottom cul-
ture dishes (MatTek Inc., USA). Fluorescence energy trans-
fer (FRET) was determined by modifying the general
equations given by Matyus (1992) as described in Bayn-
ton et al (2003) [42,47]. FRET occurs if I2 – I1(ID2/ID1) –
I3(IA2/IA3) >0 where I represents intensities in three chan-
nels given in arbitrary units between 0 and 250. Normal-
ised FRET is defined as NFRET = FRET/(I1 × I3)1/2 [48].
Intensities were measured as follows: channel 1: I1, A1, D1 =
excitation (ex.) at λ = 458, detection (det.) at 470 nm
<λ>500 nm (ECFP); channel 2: I2, D2, A2 = ex. at λ = 458
nm, det. at λ>560 nm; channel 3: I3, D3, A3= ex. at λ = 514
nm, det. at λ >560 nm (EYFP). ID1, D2, D3 and IA1, A2, A3 are
determined separately for cells transfected with only
ECFP- and EYFP-fusion proteins respectively, under the
same settings and at the same levels of fluorescence inten-
sities (I1 and I3) as co-transfected cells.
Clonogenic assays
6 well plates were seeded with 2 – 5 × 104 cells per well
and incubated overnight prior to transfecting with 6 µg
per well of plasmid DNA. The medium was replaced with
fresh 24 hours post-transfection and G418 added to a
final concentration of 1.0 mg/ml at 48 hours post-trans-
fection. Medium containing G418 was replaced as neces-
sary until 10 to 14 days post-transfection. Cells were then
washed twice in PBS, fixed for 15 minutes in ice-cold
methanol, then stained with 10% (w/v) Giemsa for 15
minutes and rinsed in water.
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